Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty

A 62-year-old Caucasian man with past medical history significant for coronary artery disease, status post drug eluting stent to the left anterior descending artery 10 years prior, was admitted for elective total right knee arthroplasty. His intraoperative course was uneventful, and he was discharge...

Full description

Bibliographic Details
Main Authors: Francisco Roman, Jay-Sheree Allen, Heather Catherine Wurm, Kathy MacLaughlin
Format: Article
Language:English
Published: SAGE Publishing 2018-08-01
Series:Journal of Primary Care & Community Health
Online Access:https://doi.org/10.1177/2150132718797446
_version_ 1819259121425186816
author Francisco Roman
Jay-Sheree Allen
Heather Catherine Wurm
Kathy MacLaughlin
author_facet Francisco Roman
Jay-Sheree Allen
Heather Catherine Wurm
Kathy MacLaughlin
author_sort Francisco Roman
collection DOAJ
description A 62-year-old Caucasian man with past medical history significant for coronary artery disease, status post drug eluting stent to the left anterior descending artery 10 years prior, was admitted for elective total right knee arthroplasty. His intraoperative course was uneventful, and he was discharged on hospital day 2 on aspirin 325 mg twice daily for 6 weeks for venous thromboembolism (VTE) prophylaxis. Three weeks later the patient developed chest pain shortly after an approximately 1-hour flight and presented to a local emergency department where computed tomography angiogram showed pulmonary emboli involving segmental and subsegmental pulmonary arteries bilaterally. He was transitioned from aspirin 325 mg twice a day to rivaroxaban 15 mg twice daily for 21 days, with a plan to transition to 20 mg daily to complete a 3-month course. He returned to his primary care physician 6 days after discharge with questions about his current anticoagulation therapy as well as the regimen he was on prior to the pulmonary embolism. Two major organizations, The American Academy of Orthopedic Surgeons and The American College of Chest Physicians, provide recommendations for VTE prophylaxis, but they differ regarding the preferred pharmacologic modality and duration. Although the goal is to provide optimal patient care, lack of guideline consensus may lead to different postoperative recommendations. It is important for clinicians to discuss with their patients the pharmacologic options available for VTE prophylaxis, how organizations differ in their recommendations, and the limitations of these pharmacologic agents.
first_indexed 2024-12-23T19:04:58Z
format Article
id doaj.art-624bcd81512142a1876edec877f67822
institution Directory Open Access Journal
issn 2150-1327
language English
last_indexed 2024-12-23T19:04:58Z
publishDate 2018-08-01
publisher SAGE Publishing
record_format Article
series Journal of Primary Care & Community Health
spelling doaj.art-624bcd81512142a1876edec877f678222022-12-21T17:34:37ZengSAGE PublishingJournal of Primary Care & Community Health2150-13272018-08-01910.1177/2150132718797446Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee ArthroplastyFrancisco Roman0Jay-Sheree Allen1Heather Catherine Wurm2Kathy MacLaughlin3Mayo Clinic, Kasson, MN, USAMayo Clinic, Kasson, MN, USAMayo Clinic, Kasson, MN, USAMayo Clinic, Kasson, MN, USAA 62-year-old Caucasian man with past medical history significant for coronary artery disease, status post drug eluting stent to the left anterior descending artery 10 years prior, was admitted for elective total right knee arthroplasty. His intraoperative course was uneventful, and he was discharged on hospital day 2 on aspirin 325 mg twice daily for 6 weeks for venous thromboembolism (VTE) prophylaxis. Three weeks later the patient developed chest pain shortly after an approximately 1-hour flight and presented to a local emergency department where computed tomography angiogram showed pulmonary emboli involving segmental and subsegmental pulmonary arteries bilaterally. He was transitioned from aspirin 325 mg twice a day to rivaroxaban 15 mg twice daily for 21 days, with a plan to transition to 20 mg daily to complete a 3-month course. He returned to his primary care physician 6 days after discharge with questions about his current anticoagulation therapy as well as the regimen he was on prior to the pulmonary embolism. Two major organizations, The American Academy of Orthopedic Surgeons and The American College of Chest Physicians, provide recommendations for VTE prophylaxis, but they differ regarding the preferred pharmacologic modality and duration. Although the goal is to provide optimal patient care, lack of guideline consensus may lead to different postoperative recommendations. It is important for clinicians to discuss with their patients the pharmacologic options available for VTE prophylaxis, how organizations differ in their recommendations, and the limitations of these pharmacologic agents.https://doi.org/10.1177/2150132718797446
spellingShingle Francisco Roman
Jay-Sheree Allen
Heather Catherine Wurm
Kathy MacLaughlin
Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
Journal of Primary Care & Community Health
title Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
title_full Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
title_fullStr Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
title_full_unstemmed Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
title_short Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
title_sort pulmonary embolism while on aspirin for venous thromboembolism prophylaxis after total knee arthroplasty
url https://doi.org/10.1177/2150132718797446
work_keys_str_mv AT franciscoroman pulmonaryembolismwhileonaspirinforvenousthromboembolismprophylaxisaftertotalkneearthroplasty
AT jayshereeallen pulmonaryembolismwhileonaspirinforvenousthromboembolismprophylaxisaftertotalkneearthroplasty
AT heathercatherinewurm pulmonaryembolismwhileonaspirinforvenousthromboembolismprophylaxisaftertotalkneearthroplasty
AT kathymaclaughlin pulmonaryembolismwhileonaspirinforvenousthromboembolismprophylaxisaftertotalkneearthroplasty